Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-08-06, Stock:NVS, The news for the past five days is as follows:
2019-07-30: NEWS1: Here's What You'll Want to Know About Incyte's Impressive Q2 Results.NEWS2: Here's What You'll Want to Know About Incyte's Impressive Q2 Results.NEWS3: Big drugmakers trade Peninsula plant as part of larger deal.NEWS4: Lilly (LLY) Q2 Earnings Beat, New Drugs Drive Sales, Stock Up.NEWS5: Lilly (LLY) Q2 Earnings Beat, New Drugs Drive Sales, Stock Up.NEWS6: Incyte (INCY) Q2 Earnings Beat Estimates, Revenues Up Y/Y.NEWS7: Incyte (INCY) Q2 Earnings Beat Estimates, Revenues Up Y/Y.NEWS8: Incyte (INCY) Q2 Earnings Beat Estimates, Revenues Up Y/Y.NEWS9: Lilly (LLY) Q2 Earnings Beat, New Drugs Drive Sales, Stock Up.NEWS10: Bayer (BAYRY) Q2 Earnings Match Estimates, Sales Up Y/Y.NEWS11: Bayer (BAYRY) Q2 Earnings Match Estimates, Sales Up Y/Y.NEWS12: Are Investors Undervaluing Novartis (NVS) Right Now?.NEWS13: Are Investors Undervaluing Novartis (NVS) Right Now?.NEWS14: Dr. Reddy's (RDY) Q1 Earnings and Revenues Increase Y/Y.NEWS15: Dr. Reddy's (RDY) Q1 Earnings and Revenues Increase Y/Y.NEWS16: Dr. Reddy's (RDY) Q1 Earnings and Revenues Increase Y/Y.NEWS17: Are Investors Undervaluing Novartis (NVS) Right Now?.NEWS18: Bayer (BAYRY) Q2 Earnings Match Estimates, Sales Up Y/Y.NEWS19: Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments.NEWS20: Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments.NEWS21: FOCUS-Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments.
2019-07-31: NEWS1: Ligand (LGND) Stock Down Despite Q2 Earnings & Sales Beat.NEWS2: Ligand (LGND) Stock Down Despite Q2 Earnings & Sales Beat.NEWS3: Gilead (GILD) Q2 Earnings & Sales Beat, Sales Guidance Raised.NEWS4: Gilead (GILD) Q2 Earnings & Sales Beat, Sales Guidance Raised.NEWS5: Ligand (LGND) Stock Down Despite Q2 Earnings & Sales Beat.NEWS6: Gilead (GILD) Q2 Earnings & Sales Beat, Sales Guidance Raised.
2019-08-01: NEWS1: United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y.NEWS2: United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y.NEWS3: United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y.
2019-08-02: NEWS1: Pharma Stock Roundup: PFE, MRK, LLY Q2 Earnings, Upjohn-MYL Merger.NEWS2: Biogen on the brink: One of the state's largest drugmakers faces a crisis.
2019-08-05: NEWS1: Aduro (ADRO) Earnings Miss in Q2, Revenues Meet Estimates.NEWS2: Aduro (ADRO) Earnings Miss in Q2, Revenues Meet Estimates.NEWS3: Aduro (ADRO) Earnings Miss in Q2, Revenues Meet Estimates.

Answer: Decrease